常用連結
1733
五鼎
生技醫療業
TWSE
2026-05-29
| 年月 |
當月營收 |
月增率 |
年增率 |
累計營收 |
累計年增率 |
走勢 |
| 2026/04 |
151,037 |
+6.83%
|
-19.34%
|
670,760 |
-10.09%
|
|
| 2026/03 |
141,377,000 |
-20.70%
|
-24.14%
|
519,723 |
-6.99%
|
|
| 2026/02 |
178,279,000 |
-10.89%
|
-12.03%
|
378,346,000 |
+1.60%
|
|
| 2026/01 |
200,067,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/12 |
170,538,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/11 |
126,710,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/10 |
156,748,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/09 |
186,470,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/08 |
183,290,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/07 |
139,800,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/06 |
152,805,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/05 |
145,225,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/04 |
139,967,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/03 |
129,686,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/02 |
129,423,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/01 |
191,549,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/12 |
109,750,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/11 |
166,338,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/10 |
134,140,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/09 |
115,344,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/08 |
147,378,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/07 |
149,769,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/06 |
129,824,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/05 |
136,814,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/04 |
150,643,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/03 |
160,102,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/02 |
135,344,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/01 |
141,091,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 序 |
持股/單位數分級 |
人數 |
股數/單位數 |
占集保庫存(%) |
比例 |
| 1 |
1-999 |
30,345 |
445 |
0.44% |
|
| 2 |
1,000-5,000 |
6,577 |
13,582 |
13.58% |
|
| 3 |
5,001-10,000 |
1,030 |
8,169 |
8.17% |
|
| 4 |
10,001-15,000 |
320 |
4,108 |
4.11% |
|
| 5 |
15,001-20,000 |
206 |
3,785 |
3.78% |
|
| 6 |
20,001-30,000 |
192 |
4,871 |
4.87% |
|
| 7 |
30,001-40,000 |
95 |
3,337 |
3.33% |
|
| 8 |
40,001-50,000 |
54 |
2,482 |
2.48% |
|
| 9 |
50,001-100,000 |
99 |
6,903 |
6.90% |
|
| 10 |
100,001-200,000 |
49 |
6,925 |
6.92% |
|
| 11 |
200,001-400,000 |
20 |
5,638 |
5.64% |
|
| 12 |
400,001-600,000 |
4 |
2,164 |
2.16% |
|
| 13 |
600,001-800,000 |
3 |
2,156 |
2.15% |
|
| 14 |
800,001-1,000,000 |
5 |
4,792 |
4.79% |
|
| 15 |
1,000,001以上 |
5 |
30,587 |
30.60% |
|
| 公司名稱 | 五鼎 |
| 英文簡稱 | ApexBio |
| 產業類別 | 生技醫療業 |
| 市場別 | 上市（TWSE） |
| 所屬集團 | — |
| 成立時間 | 1997-12-02 |
| 掛牌日期 | 2001-09-17 |
| 董事長 | 沈燕士 |
| 總經理 | 沈燕士 |
| 發言人 | 吳純慧 |
| 代理發言人 | 朱營祥 |
| 總機電話 | 03-5641952 |
| 傳真號碼 | 03567-8302 |
| 電子郵件 | info@apexbio.com |
| 公司網站 |
www.apexbio.com.tw
|
| 公司地址 | 新竹科學園區新竹巿力行五路七號 |
| 股務代理 | 台新綜合證券(股)公司股務代理部 |
| 簽證會計師 | 勤業眾信會計師事務所 |
| 股本 | 999,501,920 元 |
| 已發行普通股數 | 99,950,192 股 |
| 董監持股比例 | — |
| 市值 | 29.89 億元 |
52 週價格區間
目前位置 24.8%
低 27.00
高 38.70